IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BERNARDI, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4324
EU - Europa 2206
AS - Asia 544
SA - Sud America 12
OC - Oceania 10
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7104
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4300
PL - Polonia 601
UA - Ucraina 490
CN - Cina 460
IT - Italia 435
DE - Germania 220
IE - Irlanda 120
GB - Regno Unito 83
FR - Francia 63
SE - Svezia 63
BE - Belgio 54
FI - Finlandia 35
IN - India 24
VN - Vietnam 23
CA - Canada 19
RU - Federazione Russa 18
TR - Turchia 15
DK - Danimarca 12
AU - Australia 10
BR - Brasile 5
JP - Giappone 5
IR - Iran 4
BO - Bolivia 3
CO - Colombia 3
CU - Cuba 3
EU - Europa 3
HR - Croazia 3
RO - Romania 3
SG - Singapore 3
EG - Egitto 2
GR - Grecia 2
KR - Corea 2
MU - Mauritius 2
MY - Malesia 2
TH - Thailandia 2
AR - Argentina 1
AZ - Azerbaigian 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
JO - Giordania 1
MK - Macedonia 1
MS - Montserrat 1
MX - Messico 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 7104
Salva come PNG Salva come JPEG
Città #
Fairfield 713
Warsaw 601
Woodbridge 457
Chandler 382
Jacksonville 355
Houston 296
Ashburn 284
Wilmington 272
Ann Arbor 270
Cambridge 263
Seattle 257
Princeton 223
Brescia 138
Dublin 120
Beijing 107
Nanjing 70
Brussels 54
San Diego 48
Dearborn 46
Des Moines 46
Nanchang 37
Changsha 30
Jinan 29
Shenyang 27
Tianjin 26
Milan 24
Dong Ket 22
San Francisco 20
Jiaxing 19
London 19
Ningbo 17
Hebei 16
Kocaeli 13
Toronto 13
Barlassina 12
Hangzhou 12
Helsingør 12
Zhengzhou 11
Darfo 10
Norwalk 10
Rome 10
Kunming 9
Guangzhou 8
Genoa 6
Hanover 6
Phoenix 6
Taizhou 6
Verona 6
Bologna 5
Brooklyn 5
Haikou 5
Helsinki 5
New York 5
Redwood City 5
São Paulo 5
Augusta 4
Battipaglia 4
Como 4
Florence 4
Melbourne 4
Orange 4
Strasbourg 4
Tokyo 4
Alzano Lombardo 3
Ardabil 3
Bedford 3
Bergamo 3
Brendola 3
Canberra 3
Chiari 3
Chicago 3
Fuzhou 3
Grafing 3
La Habana 3
Lanzhou 3
Monza 3
Nürnberg 3
Pavia 3
Rockville 3
Sucre 3
Turin 3
Bangkok 2
Bucaramanga 2
Buffalo 2
Casanova Lonati 2
Collegeville 2
Core 2
Halifax 2
Leonberg 2
Lumezzane 2
Marcheno 2
Mcallen 2
North York 2
Padova 2
Pescara 2
Piemonte 2
Redmond 2
San Mateo 2
Shah Alam 2
Singapore 2
Totale 5597
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 251
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 232
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 217
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 202
Zebrafish disease models in hematology: Highlights on biological and translational impact 162
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 159
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 123
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 118
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 115
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 114
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 113
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 110
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 106
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 105
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 104
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 103
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 101
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 101
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 98
Alterations of AQP2 expression in trigeminal ganglia in a murine inflammation model 96
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation 94
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 92
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 91
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 87
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 86
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 85
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 84
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 84
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 83
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 83
WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. 82
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 82
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 80
Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor 78
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 77
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 75
Extracellular Vesicles: From Biomarkers to Therapeutic Tools 74
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome 71
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 71
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 68
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 66
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 65
Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message? 63
Genomic Analysis Of Notch Mutations In a Case Of Alagille Syndrome With Acute Lymphoblastic Leukemia 61
EARLY EXTRACORPOREAL PHOTOAPHERESIS FOR THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE (AGVHD). 60
PYROSEQUENCING IS A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY. 60
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 60
AZACITIDINE (AZA) FOR RELAPSED HIGH RISK MYELODYSPLASIC SYNDROME AFTER INTRABONE CORD BLOOD TRANSPLANTATION: A CASE REPORT. 59
BRENTUXIMAB SALVAGE THERAPY IN HODGKIN LYMPHOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE. 59
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO EVALUATE THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION 59
ACHIEVEMENT OF COMPLETE REMISSION WITH PONATINIB THERAPY FOR PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A CASE REPORT. 58
THE PYROSEQUENCING: A NEW PROMISING APPROACH TO PERFORM HLA TYPING AND SELECT THE STEM CELL DONOR IN A QUICKLY, SIMPLE AND ACCURATE WAY 58
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 58
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 56
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 56
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 55
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 54
PROGNOSTIC RELEVANCE OF WT1 MOLECULAR LEVELS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. 53
COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS (MSC) AND STIMULATORY CYTOKINES ON THE ex vivo GROWTH OF UMBILICAL CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS (UCB-HPC) 53
EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: AN ITALIAN MULTICENTRIC RETROSPECTIVE ANALYSIS ON 94 PATIENTS ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO) 53
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 53
Advances in CMV Management: A Single Center Real-Life Experience 53
PROFILE OF TOLL-LIKE RECEPTORS ON MONOCYTES AND LYMPHOCYTES IN RELATION TO INFECTIOUS COMPLICATIONS AND OUTCOME IN ALLOGENEIC STEM CELL TRANSPLANTATION. 52
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 51
MULTI-GENOTYPE OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO STUDY GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION. 50
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 50
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 48
Detection of newly produced T and B lymphocytes by digital PCR in blood stored dry on nylon flocked swabs 47
Minimal residual disease monitoring in acute myeloid leukaemia: are we ready to move from bone marrow to peripheral blood? 47
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 46
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 46
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 46
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 45
HLA-TYPING BY PYROSEQUENCING TECHNOLOGY: A NEW PROMISING QUICKLY AND ACCURATE APPROACH WITHOUT PHASE AMBIGUITIES. 44
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 44
FAILURE TO REPLICATE THE ASSOCIATION OF UROMODULIN GENE VARIANT RS 13333226 WITH HYPERTENSION IN A GENERAL POPULATION STUDY 43
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 43
Co-isolation and analysis of extracellular vesicle (EV)-associated DNA and cell free DNA (cfDNA) to improve the diagnostic and prognostic value of circulating BRAF V600E in metastatic melanoma patients 43
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 43
COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS AND STIMULATORY CYTOKINES ON THE IN VITRO GROWTH OF UCB HEMATOPOIETIC PROGENITOR CELLS. 40
IS PI-PLC 1 EXPRESSION A RELIABLE PREDICTOR OF RESPONSE IN LOW RISK MDS PATIENTS TREATED WITH LOW-DOSE AZACITIDINE? RESULTS OF A PROSPECTIVE MULTICENTRIC STUDY. 38
Molecular response and Quality of Life (QoL) in Chronic Myeloid Leukemia (CML) patients treated with Intermittent TKIs: first interim analysis of OPTkIMA Study 38
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 36
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients 36
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point? 33
Mineralization of 3D Osteogenic Model Based on Gelatin-Dextran Hybrid Hydrogel Scaffold Bioengineered with Mesenchymal Stromal Cells: A Multiparametric Evaluation 33
dsDNA from extracellular vesicles (EVs) in adult AML 32
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 32
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 32
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 31
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 29
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 29
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 29
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 29
Achievement of complete remission with Ponatinib therapy for Philadelphia positive acute lymphoblastic leukemia relapsed after allogeneic stem cell transplantation: a case report 28
Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These “Magic Bullets” 27
Abstract 90: A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 26
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis 26
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 24
Abstract A27: European Network NGS-PTL preliminary data: Whole exome sequencing identifies mutations of ALDH2, RETSAT, HSPG2, CHPF and other metabolic genes as a novel functional category in acute myeloid leukemia 24
Totale 7069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201826 0000 00 00 00026
2018/2019578 13201714 5624 5971 255895126
2019/20201919 1795460149 117196 216221 20529295135
2020/20211928 45148101269 79230 73216 163329168107
2021/20221076 891014465 3975 5373 6414976248
2022/20231116 157504590 116234 19123 17628726
Totale 7388